Insulin-like growth factor binding proteins and their role in controlling IGF actions

Cytokine and Growth Factor Reviews

Volumn 8, Issue 1, 1997, Pages 45-62

  Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Growth hormone (GH); IGF binding proteins (IGFBPs); IGF receptors; IGFBP proteases; Insulin like growth factor 1 or II (IGF I or II); Serine and matrix metalloproteases

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

AMINO ACID SEQUENCE; ANIMAL; BINDING AFFINITY; CHEMICAL STRUCTURE; CHEMISTRY; ENDOCRINE GLAND; EXTRACELLULAR MATRIX; GENETICS; HUMAN; MOLECULAR GENETICS; NONHUMAN; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY;

EID: 0031105225     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(96)00053-6     Document Type: Short Survey

References (153)

1. Zapf J, Waldvogel M, Froesch ER. Binding of non-suppressible insulin-like activity to human serum: Evidence for a carrier protein. Arch Biochem Biophys 1975, 168, 638-645.
2. Hintz RL, Liu F. Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocr Metab 1977, 45, 988-995.
3. Furlanetto RW. Somatomedin binding protein: Evidence for heterogenous subunit structure. J Clin Endocr Metab 1980, 51, 12-19.
4. Drop SLS, Kortleve DJ, Guyda HJ. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay. J Clin Endocr Metab 1984, 59, 899-907.
5. Povoa G, Enberg G, Jornvall H, Hall K. Isolation and characterization of a somatomedin binding protein from mid term human amniotic fluid. Eur J Biochem 1984, 144, 199-204.
6. Brewer MT, Stetler GL, Squires CH, Thompson RC, Busby WH, Clemmons DR. Cloning, characterization and expression of a human insulin-like growth factor binding protein. Biochem Biophys Res Commun 1988, 152, 1289-1297.
7. Lee YL, Hintz RL, James DM, Lee PDK, Shively JE, Powell DR. Insulin like growth factor IGF binding protein complementary deoxyribonucleic acid from human Hep G2 hepatoma cells: predicted protein sequence suggests and IGF binding domain different from those of IGF-I and IGF-II receptors. Molec Endocr 1988, 3, 404-411.
8. Brown AL, Chiariotti L, Orlowski CC, et al. Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors. J Biol Chem 1989, 264, 5148-5154.
9. Martin JL, Baxter RC. Insulin like growth factor binding protein from human plasma, purification and characterization. J Biol Chem 1986, 261, 8754-8760.
10. Wood, WI, Cachianes G, Henzel WJ, et al. Cloning and expression of the GH dependent insulin like growth factor binding protein. Molec Endocr 1988, 2, 1176-1185.
11. Shimasaki S, Shimonaka M, Zhang HP, Ling N. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP in rat and human. J Biol Chem 1991, 266, 10,646-10,653.
12. Drop SLS, Kortleve DJ, Guyda HJ, Posner BI. Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal, and adult sera. J Clin Endocr Metab 1984, 59, 908-915.
13. Baxter RC, Martin, JL. Radioimmunoassay of growth hormone dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986, 78, 1504-1512.
14. Baxter RC. Physiological roles of the IGF binding proteins, In Spencer EM ed. Modern Concepts of Insulin-like Growth Factors. New York, Elsevier, 1991, 371-380.
15. Streck RD, Wood TL, Hsu MS, Pintar JE. Insulin-like growth factor I and II and insulin-like growth factor binding protien-2 mRNAs are expressed in adjacent tissues within rat embryonic and fetal limbs. Dev Biol 1992, 151, 586-596.
16. Jennische E, Skottner A, Hansson HA. Dynamic changes in insulin-like growth factor I immunoreactivity correlate with repair events in rat ear after freeze -thaw injury. Exp Molec Pathol 1987, 47, 193-201.
17. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinstre RL, D'Ercole AJ. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone deficient transgenic mice. Endocrinology 1990, 127, 1033-1040.
18. DeChiara RM, Efstratiadis A, Robertson EJ. A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disruption. Nature 1990, 345, 78-80.
19. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying small mutations of the genes encoding insulin like growth factor I (IGF-I) and type 1 IGF receptor (IGF/r). Cell 1993, 75, 73-82.
20. Camacho-Hubner C, Busby WH, McCusker RH, Wright G, Clemmons DR. Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 1992, 267, 11,949-11,956.
21. Cerro JA, Grewal A, Wood TL, Pintar JE. Tissue-specific expression of insulin-like growth factor binding protein (IGFBP) mRNAs in mouse and rat development. Regul Peptide 1993, 48, 189-198.
22. Rechler MM. Insulin like growth factor binding proteins. Vitamins and Hormones 1993, 47, 1-114.
23. Hossenlopp P, Seurin D, Segovia B, Portolan G, Binoux M. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 2. Forms released by human and rat liver in culture. Eur J Biochem 1987, 170, 133-142.
24. Unterman TG, Oehler DT, Murphy LJ, Lacson RG. Multihormonal regulation of insulin like growth factor binding protein-1 in rat H4 IIE hepatoma cells: the dominant role of insulin. Endocrinology 1991, 128, 2693-2701.
25. Ooi GT, Tseng LY, Tran MQ, Rechler MM. Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozoticin-diabetic rats. Molec Endocr 1992, 6, 2219-2228.
26. Swanichkul A, Allander SV, Morris SL, Powell DR. Glucorticoids and insulin regulate expression of the human gene for insulin like growth factor binding protein-1 through proximal promoter elements. Proc Natl Acad Sci USA 1994, 269, 30,835-30,841.
27. Strauss DS, Takemoto CD. Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-1 gene transcription in rat liver. Molec Endocr 1990, 4, 91-100.
28. Adamo ML, Shao ZM, Lanau F, et al. Insulin like growth factor I (IGF-I) and retinoic acid modulation of IGF binding proteins (IGFBPs). IGFBP-2, 3 and 4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 1992, 131, 1858-1866.
29. Wood TL, Brown AL, Rechler MM, Pintar JE. The expression pattern of an insulin like growth factor (IGF) binding protein gene is distinct from IGF-II in mid gestation embryo. Molec Endocr 1990, 4, 1257-1263.
30. Wood TL, Rogler L, Pintar JE. Targeted gene disruption of the IGFBP-2 gene. Growth Regul 1993, 3, 5-8.
31. Adamo ML, Bach MA, Roberts CT, LeRoith D. Regulation of insulin IGF-I and IGF-II gene expression. In LeRoith D ed. Insulin-like Growth Factors: Molecular and Cellular Aspects. Boca Raton, FL, CRC Press, 1990, 271-303.
32. Walker JL, Ginalska-Malinowska M, Romer TC, Pucilowska JB, Underwood LE. Effects of infusion of insulin-like growth factor-I in a child with growth hormone insensitivity syndrome. N Engl J Med 1991, 324, 1483-1488.
33. Baxter RC, Martin JL. Binding proteins for insulin-like growth factors: structure, regulation and function. Progr Growth Fact Res 1989, 1, 49-68.
34. Takenada A, Miura Y, Mori A, Hirosawa M, Kato H, Noguchi T. Distribution of mRNAs of insulin-like growth factor binding proteins 1 and 3 between parenchymal and non-parenchymal cells in the liver. J Biol Chem 1991, 55, 1191-1193.
35. Booth BA, Bar RS, Boes M, Dake BL, Bayne ML, Cascieri MA. Intrinsic bioactivity of insulin-like growth factor binding proteins from endothelial cells. Endocrinology 1990, 6127, 2630-2638.
36. Rechler MM, Nissley SP. Insulin-like growth factors. In Peptide Growth Factors and Their Receptors. Berlin, Springer, 1993, 263-287.
37. T 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity labeling. Proc Natl Acad Sci USA 1989, 86, 6898-6902.
38. Guler H-P, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocr 1989, 121, 753-758.
39. Dai J, Baxter RC. Regulation of acid labile subunit of the rat serum insulin-like growth factor binding protein complex. Endocrinology 1994, 135, 1066-1072.
40. Hodgkinson SC, Davis SR, Moore LG, Henderson HV, Gluckman PD. Metabolic clearance of insulin-like growth factor-II in sheep. J Endocr 1989, 123, 461-468.
41. Dai J, Baxter RC. Regulation in vivo of acid labile subunit of the rat serum insulin like growth factor binding protein complex. Endocrinology 1994, 135, 2335-2341.
42. Zapf J, Schmid C, Guler HP, et al. Regulation of binding proteins for insulin-like growth factors in humans: Increased expression of IGF binding proteins during treatment of healthy adults and in patients with extrapancreatic tumor. J Clin Invest 1990, 86, 952-961.
43. Camacho-Hubner C, Clemmons DR, D'Ercole AJ. Regulation of insulin-like growth factor binding proteins in transgenic mice with altered expression of growth hormone and IGF-I. Endocrinology 1991, 129, 1201-1206.
44. Daughaday WH, Kapadia M. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet cell tumors. Proc Natl Acad Sci USA 1989, 86, 6778-6782.
45. Boni-Schnetzler M, Binz K, Mary J-L, Schmid C, Schwander J, Froesch ER. Regulation of hepatic expression of IGF I and fetal IGF binding protein mRNA in streptozotocin-diabetic rats. Fedn Eur Biochem Socs Lett 1989, 251, 253-256.
46. Clemmons DR, Busby WH, Snyder DK. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocr Metab 1991, 73, 727-733.
47. Straus DS, Takemoto CD. Effect of dietary protein deprivation insulin-like growth factor IGF-I and II, IGF binding protein-2 and serum albumin gene expression in the rat. Endocrinology 1990, 127, 1849-1860.
48. Busby WH, Snyder DK, Clemmons DR. Radioimmunoassay of a 26,000 dalton plasma insulin like growth binding protein: control by nutritional variables. J Clin Endocr Metab 1988, 67, 1225-1230.
49. Suwannichkul A, Allander SV, Morris SL, Powell DR. Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor binding protein-1 through proximal promoter elements. J Biol Chem 1996, 269, 30,835-30,841.
50. O'Brien RM, Lucas PC, Forest CD, Magneson MH, Granner DK. Identification of the sequence in the PEPCK gene that mediates the systemic effect of insulin on transcription. Science 1990, 249, 533-537.
51. Bar RS, Boes M, Clemmons DR, et al. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF binding proteins in rat heart. Endocrinology 1990, 127, 497-499.
52. Lewitt MS, Sanders H, Baxter RC. Bioavailability of insulin like growth factors (IGF's) in rats determined by molecular distribution of human IGF binding protein-3. Endocrinology 1993, 133, 1797-1802.
53. Senevirantre C, Jiangming L, Murphy LJ. Transcriptional regulation of rat insulin like growth factor binding protein-1 expression by growth hormone. Molec Endocr 1990, 4, 1199-1204.
54. Luo J, Murphy LJ. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology 1989, 125, 165-171.
55. Ooi GT, Orlowski, CC, Brown AL, Becker RE, Unterman TG, Rechler MM. Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor binding proteins-1 and 2. Molec Endocr 1990, 4, 321-328.
56. O'Brien RM, Noisen RL, Sandwich L, et al. Hepatic membrane factor 3 and hormone regulated responsiveness of PEPCK and insulin-like growth factor binding protein-1 genes. Molec Cell Biol 1994, 203, 1835-1841.
57. Honda Y, Landale EC, Strong DD, Baylink DJ, Mohan S. Recombinant synthesis of insulin-like growth factor binding protein-4: Development of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocr Metab 1996, 81, 1389-1396.
58. Binoux M, Roghani M, Hassenlopp P, Harudin S, Gourmelen M. Molecular forms of human IGF binding proteins: Physiological implications. Acta Endocr 1991, 124 (Supp 2), 41-47.
59. Zapf J, Keifer MC, Merryweather J, et al. Isolation from adult human serum forms of insulin-like growth factor binding proteins and molecular cloning of one of them that is increased by IGF-I administration. J Biol Chem 1990, 265, 14,892-14,898.
60. Jones JI, Gockerman A, Busby WH, Jr. Wright G, Clemmons DR. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993, 90, 10,553-10,557.
61. Chernausek SD, Smith CE, Duffin KL, Busby WH, Wright G, Clemmons DR. Proteolytic cleavage of insulin like growth factor binding protein-4 (IGFBP-4). J Biol Chem 1995, 270, 11,377-11,382.
62. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR. Phosphorylation of insulin-like growth factor binding protein in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci 1991, 88, 7481-7485.
63. Elgin RG, Busby WH, Clemmons DR. An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 1987, 84, 3254-3258.
64. McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA, Clemmons DR. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 1990, 144, 244-253.
65. DeMellow JSM, Baxter RC. Growth hormone dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in skin fibroblasts. Biochem Biophys Res Commun 1988, 156, 199-204.
66. Jones JI, Gockerman A, Busby WH, Camacho-Hubner C, Clemmons DR. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 1993, 121, 679-687.
67. Clemmons DR, Underwood LE, Chatelain PG, Van Wyk JJ. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin. J Clin Endocr Metab 1983, 56, 384-389.
68. Lassare C, Binoux M. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology 1994, 134, 1254-1262.
69. Lee CY, Rechler MM. Proteolysis of insulin-like growth factor binding protein-3 in 150 kilodalton IGFBP complexes by a cation dependent protein activity in adult rat serum promotes the release of IGF-I. Endocrinology 1995, 136, 4982-4989.
70. Hossenlopp P, Segovia B, Lassare C, Roghani M, Bredon M, Binoux M. Enzymatic evidence of degradation of insulin-like growth factor binding protein in 150 k complex during pregnancy. J Clin Endocr Metab 1990, 71, 797-805.
71. Guidice LC, Farrell EM, Pham H, Lamson FG, Rosenfeld RG. Insulin like growth factor binding proteins in maternal serum throughout gestation and in the puerperium. J Clin Endocr Metab 1990, 71, 806-816.
72. Davenport ML, Clemmons DR, Miles MV, Catnacho-Hubner C, D'Ercole AJ, Underwood LE. Regulation of serum insulin-like growth factor I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 1990, 127, 1278-1286.
73. Fowlkes J, Enghild JJ, Suzukik N, Nagase H. Matrix metalloproteases degrade insulin like growth factor binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994, 269, 25,742-25,746.
74. Bang P, Brismar K, Rosenfeld RG, Hall K. Fasting affects serum insulin-like growth factor (IGFs) and IGF binding proteins differently in patients with NIDDM versus non-obese and obese weight matched healthy subjects. J Clin Endocr Metab 1994, 78, 960-966.
75. Fielder PJ, Guevara-Aguirre J, Rosenbloom AL, Carlsson L. Hintz RL, Rosenfeld RG. Expression of insulin-like growth factors, IGF binding proteins and growth hormone binding proteins in heterozygous relatives of Ecuadorian GH receptor deficient patients. J Clin Endocr Metab 1992, 74, 743-750.
76. Cwyfan-Hughes SC, Cotterill AM, Molloy AR. Induction of specific proteases for insulin-like growth factor binding protein following major heart surgery. J Endocr 1992, 135, 135-145.
77. Davenport ML, Isley WL, Pucilowska J, et al. Insulin-like growth factor binding protein-3 proteolysis is induced following elective surgery. J Clin Endocr Metab 1992, 130, 2505-2512.
78. Blat C, Villaudy J, Binoux M. In vivo proteolysis of serum insulin-like growth factor binding protein-3 results in minimal availability of IGF to target cells. J Clin Invest 1994, 93, 2286-2290.
79. Cohen P, Graves HC, Peehl D, Kamasei M, Guidice LC, Rosenthal RG. Prostate specific antigen PSA is an insulin-like growth factor binding protein-3 protease found in seminal plasma 2. Clin Endocr Metab 1992, 75, 1046-1054.
80. Conover CA, DeLeon DD. Acid-activated insulin-like growth factor binding protein-3 proteolysis in normal and transformed cells: role of cathepsin-D. J Biol Chem 1994, 269, 7076-7080.
81. Lalou C, Binoux M. Evidence that proteolysis of insulin-like growth factor binding protein-3 occurs in the normal state outside of the bloodstream. Regul Pept 1993, 48, 179-188.
82. Gargosky SE, Pham H, Wilson KF, Liu F, Guidice LC, Rosenfeld RG. Measurement and characterization of insulin-like growth factor binding protein-3 in human biologic fluids discrepancy between radioimmunoassays and ligang blotting. Endocrinology 1992, 131, 3051-3060.
83. Davenport ML, Pucilowska J, Clemmons DR, Lundblad R, Spencer JA, Underwood LE. Tissue specific expression of IGFBP-3 protease activity during rat pregnancy. Endocrinology 1992, 75, 590-595.
84. McCusker RH, Campion DR, Jones WK, Clemmons DR. The insulin-like growth factor-binding proteins of porcine serum: endocrine and nutritional regulation. Endocrinology 1989, 125, 501-509.
85. Pucilowska JB, Davenport ML, Kabir I, et al. The effect of dietary protein supplementation on insulin like growth factors (IGF's) and IGF binding proteins in children with shigellosis. J Clin Endocr Metab 1993, 77, 1516-1521.
86. Gockerman A, Clemmons DR. Porcine aortic smooth muscle cells secrete a serine protease for insulin like growth factor binding protein-2. Circ Res 1995, 76, 514-521.
87. Nam TJ, Busby WH, Clemmons DR. Human fibroblasts secrete a serine protease that cleaves insulin like growth factor binding protein-5. Endocrinology 1994, 135, 1385-1391.
88. Andress DL, Birnbaum RS. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 1992, 267, 22,467-22,472.
89. Thrailkill KM, Quarles ID, Nagase H, Suzuki K, Serra DM, Fowlkes JL. Characterization of insulin-like growth binding protein-5 degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 1995, 136, 3527-3534.
90. Nam TJ, Busby WH, Jr, Clemmons DR. Characterization and determination of the relative abundance of two types of IGFBP-5 proteases that are secreted by human fibroblasts. Endocrinology in press.
91. Cheung PT, Wu J, Banach W, Chernausek S. Glucocorticoid regulation of insulin-like growth factor binding protein-4 protease by a rat neural cell line. Endocrinology 1994, 135, 798-806.
92. Hassager CL, Fitzpatrick LA, Spencer EM, Riggs FL, Conover CA. Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. J Clin Endocr Metab 1992, 75, 228-233.
93. Parker A, Gockerman A, Busby WH, Clemmons DR. Properties of an insulin like growth factor binding protein 4 protease that is secreted by smooth muscle cells. Endocrinology 1995, 135, 2470-2476.
94. Durham SK, Keifer MR, Riggs BL, Conover CA. Regulation of insulin like growth factor binding protein-4 by a specific insulin like growth factor binding protein-4 protease in normal human osteoblast like cells. Implications on human cell physiology. J Bone Mineral Res 1994, 9, 111-117.
95. Jones JI, Busby WH, Wright G, Smith CE, Kimack NM, Clemmons DR. Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1: Regulation of its affinity by phosphorylation of serine 101. J Biol Chem 1993, 268, 1125-1131.
96. Ankrapp DP, Jones JI, Clemmons DR. Characterization of insulin like growth factor binding protein-1 kinases from human hepatoma cells. J Cell Biochem 1996, 60, 387-399.
97. Westwood M, Gibson JM, White A. Purification and characterization of the IGFBP-1 phosphoform found in normal plasma. Presented to the 5th International Insulin and IGF Symposium. Abstract no. 14 1995, 3-5 March.
98. Hoeck WG, Mukku VR. Identification of the major sites of phosphorylation in IGF binding protein-3. J Cell Biochem 1994, 56, 262-273.
99. Baxter RC. Glycosaminoglycans inhibit formation of the 140 kDa insulin like growth factor binding protein complex. Biochem J 1990, 271, 773-777.
100. Conover CA. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism. Endocrinology 1992, 130, 3191-3199.
101. Arai T, Parker AJ, Busby WH, Clemmons DR. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. J Biol Chem 1994, 269, 20,388-20,393.
102. Ritvos O, Ranta T, Jalkanen J, et al. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 1988, 122, 2150-2157.
103. Okajina T, Iwashita M, Takeda Y, et al. Inhibitory effects insulin-like growth factor binding proteins 1 and 3 on IGF activated glucose consumption in mouse Balb/c3T3 fibroblasts. J Endocr 1993, 133, 457-470.
104. Rutanen E-M, Pekonen F, Makinen T. Soluble 34 K binding protein inhibits the binding of insulin-like growth factor I to its own well receptors in human secretory phase endometrium: evidence for autocrine paracrine regulation of growth factor action. J Clin Endocr Metab 1988, 66, 173-180.
105. Frauman AG, Tsuzaki S, Moses AC. The binding characteristics and biological effects in FRTL5 cells of placental protein-12. and insulin-like growth factor-binding protein purified from human amniotic fluid. Endocrinology 1989, 124, 2289-2296.
106. Cox GN, McDermott MJ, Merkel E, et al. Recombinant human insulin-like growth factor binding protein-1 inhibits growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 1994, 35, 1913-1920.
107. D'Ercole AJ, Dai Z, Xing Y, et al. Human insulin-like growth factor binding protein-1 (hIGFBP-1) transgenic mice: characterization and insights into the regulation of IGFBP-1 expression. Devl Brain Res 1994, 82, 213-222.
108. Rajkumar K, Barron D, Lewitt M, Murphy LJ. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995, 136, 4029-4034.
109. Busby WH, Klapper DG, Clemmons DR. Purification of a 31000 dalton insulin-like growth factor binding protein from human amniotic fluid. J Biol Chem 1988, 263, 14,203-14,210.
110. Clemmons DR, Cascieri MA, Camacho-Hubner C, McCusker RH, Bayne ML. Discrete alterations of the IGF-I molecule that alter its affinity for IGF binding proteins result in changes in bioactivity. J Biol Chem 1990, 265, 12,210-12,216.
111. Koistinen R, Itkinen P, Selenius P, Seppala M. Insulin like growth factor binding protein-1 inhibits binding of IGF-1 on fetal skin fibroblasts but stimulates their DNA synthesis. Biochem Biophys Res Commun 1990, 173, 408-415.
112. Kratz G, Lake M, Ljungstrom K, Forsberg G, Haegerstrand A, Gidlund M. Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-I but not IGF-II induced cell proliferation. Exp Cell Res 1992, 202, 381-385.
113. Jyung RW, Mustoe T, Busby WH, Clemmons DR. Increased wound breaking strength induced by insulin-like growth factor-1 in combination with IGF binding protein-1. Surgery 1994, 115, 223-239.
114. Frost JP, Tseng LT. Insulin-like growth factor binding protein-1 is phosphorylated by cultured human endometrial cells and multiple protein kinases in vitro. J Biol Chem 1991, 266, 18,082-18,088.
115. Tsuboi R, Shi CM, Sato C, Cox GN, Ogawa H. Coadministration of insulin like growth factor (IGF-I) and IGF binding protein-1 stimulates wound healing in animal models. J Invest Dermatol 1995, 104, 199-203.
116. Gockerman A, Jones JI, Prevette T, Clemmons DR. Insulin like growth factor binding protein-2 inhibits smooth muscle cell migration response to IGF-I. Endocrinology 1995, 136, 4168-4173.
117. Delhanty PJD, Han VKM. An RGD to RGE mutation in the putative membrane binding domain of IGFBP-2 inhibits its potentiation of IGF-II induced thymidine uptake by SCP cell. Presented to the 75th Annual Meeting of the Endocrine Society. Las Vegas, NV. 1993, Abstract 2256.
118. Knauer DJ, Smith GL. Inhibition of biologic activity of multiplication stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 1980, 77, 7252-7254.
119. Ross M, Francis GL, Szabo L, Wallace JC, Ballard FJ. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-2 but not des(1-3)-IGF-I. Biochem J 1989, 258, 267-272.
120. Feyen JH, Evans DB, Binkert C, Heinrich GF, Gaisse S, Koeher HP. Recombinant human CYS 281 insulin like growth factor binding protein-2 inhibits both basal and insulin like growth factor I stimulated proliferation and collagen synthesis in fetal rat calvaria. J Biol Chem 1991, 266, 19,469-19,474.
121. Pintar JE, Schuller A, Cerro JA, Czick M, Grewal A, Green B. Genetic ablation of IGFBP-2 suggests functional redundancy in the IGFBP family. Progr Growth Fact Res 1995, 6, 437-445.
122. Bar RS, Booth BA, Bowes M, Drake BL. Insulin-like growth factor binding proteins from cultured endothelial cells: Purification, characterization, and intrinsic biologic activities. Endocrinology 1989, 125, 1910-1920.
123. Bourner MJ, Busby WH, Siegel NR, Krivi GG, McCusker RH, Clemmons DR. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of it structural and functional properties with IGFBP-1. J Cell Biochem 1992, 48, 215-226.
124. Blat C, Delbe J, Villaudy J, Chatelain PG, Golde A, Harel L. Inhibitory diffusible factor-45 bifunctional activity as a cell growth inhibitor and as an insulin-like growth factor I-binding protein. J Biol Chem 1989, 264, 12,449-12,454.
125. Villaudy J, Delbe J, Blat C, Desaulty G, Gole A, Harel L. An IGF binding protein is an inhibitor of IGF stimulation. J Cell Physiol 1991, 149, 492-496.
126. Bicsak TA, Shimonaka M, Malkowski M, Ling N. Insulin-like growth factor binding protein-3 inhibition of granulosa cell function effect on cycle 3′5′ monophosphate, deoxyribonucleic acid synthesis and comparison of effect of IGF-I antibody. Endocrinology 1990, 126, 2184-2189.
127. Schmid C, Rutishauser J, Schlapfer I, Froesch ER, Zapf J. Intact but not truncated insulin-like growth factor binding protein-3 blocks IGF-I induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3 specific proteolysis. Biochem Biophys Res Commun 1991, 179, 579-585.
128. Earnst M, Rodan GA. Increased activity of IGF-I osteoblastic cells in the presence of GH: positive correlation with the presence of GH induced IGFBP-3. Endocrinology 1990, 127, 807-814.
129. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR. Insulin-like growth factor I (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology 1989, 125, 766-772.
130. Sommer A, Maceck C, Spratt KS, et al. Molecular genetics and actions of recombinant insulin like growth factor binding protein-3. In Modern Concepts of Insulin-like Growth Factors. New York, Elsevier, 1991, 715-728.
131. Clark PG, Mortensen D, Reigsupreder D, Mohler M, Etchevery T, Mukkev V. Recombinant human insulin like growth factor binding protein 3: Effects on the glycine and growth promotions activities of rh IGF-I in the rat. Growth Regul 1993, 3, 46-50.
132. Bagi CM, Brommage R, Adams SO, Rosen DM, Sommer A. Benefit of systemically administered rh IGF-I and rh IGF-I/IGBP-3 on cancellous bone in oophorectomized rats. J Bone Mineral Res 1994, 9, 1301-1312.
133. Stewart CH, Bates DC, Calder TA, Woddell SM, Pell JM. Potentiation of insulin like growth factor (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology 1993, 133, 1462-1465.
134. van Buul-Offers SC, Reijen-Gresnigt R, Bloenen R, Hoogerbrugge C, van den Brande JL. Co-administration of IGF-I binding protein-3 differentially inhibits IGF-I induced total body organ growth of Snell dwarf mice. Progr Growth Fact Res 1995, 6, 377-383.
135. Neuschwander S, Schwartz A, Wood TL, Roberts C, Henninghauser L, LeRoith D. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 1996, 97, 2225-2232.
136. Liu L, Delbe J, Blat C, Zapf J, Harel L. Insulin-like growth factor protein-3 (IGFBP-3) is an inhibition of serum growth factors other than IGF-I and IGF-II. J Cell Physiol 1992, 153, 15-21.
137. Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin like growth factor (IGF) independent actions of IGF binding protein-3 in HS578 in human breast carcinoma cells. J Biol Chem 1993, 268, 14,964-14,971.
138. Oh Y, Muller HL, Pham H, Rosenfeld RG. Demonstration of receptors of insulin-like growth factor binding protein-3 on HS578T breast cancer cells. J Biol Chem 1996, 268, 26,045-26,048.
139. Mohan S, Bautista CM, Wergedal J, Baylink DJ. Isolation of inhibitory insulin-like growth factor (IGF) binding protein from bone cell conditioned medium: a potential local regulator of IGF action. Proc Natl Acad Sci USA 1989, 86, 8338-8342.
140. Ui M, Shimonaka M, Shimasaki S, Ling N. An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells. Endocrinology 1989, 125, 912-916.
141. Coulouscou JM, Shoyab M. Purification of a colon cancer cell growth inhibitor and its Identification as insulin-like growth factor binding protein-4. Cancer Res 1991, 51, 2813-2819.
142. Jones JI, Clemmons DR. Insulin like growth factor and their binding proteins: biologic actions. Endocr Rev 1995, 16, 3-34.
143. Cohick WS, Gockerman A, Clemmons DR. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin like growth factors. J Cell Physiol 1993, 157, 52-60.
144. Conover CA, Keifer MC, Zapf J. Post translational regulation of insulin like growth factor binding protein 4 in normal and transformed human fibroblasts. J Clin Invest 1993, 91, 1129-1137.
145. Conover CA, Durham SK, Zapf J, Masiarz FR, Keifer MC. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J Biol Chem 1995, 270, 4395-4400.
146. Keifer MC, Schmid C, Waldvogel M, et al. Characterization of recombinant human insulin-like growth factor binding proteins-4, -5, and -6 produced in yeast. J Biol Chem 1992, 267, 12,692-12,699.
147. Ling NC, Liu XJ, Malkowski M, Guo YL, Erickson GF, Shimasaki S. Structural and functional studies of insulin-like growth factor binding proteins in the ovary. Growth Regul 1993, 3, 70-74.
148. Bautista CM, Baylink DJ, Mohan S. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 1991, 176, 756-763.
149. Andress DL, Loop SM, Zapf J, Kiefer MC. Carboxy truncated insulin like-growth factor binding protein-5 stimulates mitogenesis in osteoblast like cells. Biochem Biophys Res Commun 1993, 195, 25-30.
150. Andress DL. Heparin modulates the binding of insulin/like growth factor (IGF) binding protein 5 to a membrane protein in osteoblastic cells. J Biol Chem 1995, 270, 28,289-28,296.
151. Conover CA, Keifer MC. Regulation of biological effect of endogenous insulin like growth factor binding protein 5 in human osteoblast cells. J Clin Endocr Metab 1993, 76, 1153-1159.
152. Arai T, Clarke S, Parker A, Busby WH, Clemmons DR. Effect of substitution of specific amino acids in insulin like growth factor binding protein-5 on heparin binding and its change in affinity for IGF-I in response to heparin. J Biol Chem 1996, 271, 6099-6106.
153. Parker A, Busby WH, Clemmons DR. Identification of the extracellular matrix bonding site for insulin like growth factor binding protein-5. J Biol Chem 1996, 271, 13,523-13,529.